| P2093 | author name string | Stuart A Lipton | |
| | Laurence M Brill | |
| | Scott R McKercher | |
| | Shing Fai Chan | |
| | Nobuki Nakanishi | |
| | Shu-Ichi Okamoto | |
| | Mohd W Akhtar | |
| | Rameez Zaidi | |
| | Sam Sances | |
| P2860 | cites work | A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation | Q24305050 |
| | bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death | Q24312157 |
| | A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage | Q24324031 |
| | Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis | Q24534050 |
| | Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry | Q24561920 |
| | MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex | Q24563497 |
| | Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system | Q24650727 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| | Substrate specificities and identification of putative substrates of ATM kinase family members | Q28141080 |
| | DNA double-strand breaks: signaling, repair and the cancer connection | Q28204231 |
| | DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation | Q28206029 |
| | MEF2: a calcium-dependent regulator of cell division, differentiation and death | Q28215798 |
| | Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells | Q28235590 |
| | Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number | Q28297899 |
| | Transcription factor ATF2 regulation by the JNK signal transduction pathway | Q28305631 |
| | The expression of MEF2 genes is implicated in CNS neuronal differentiation | Q28511872 |
| | bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death | Q28513006 |
| | Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells | Q28591351 |
| | Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice | Q28593143 |
| | Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. | Q48049816 |
| | Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. | Q48226926 |
| | Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia | Q48824906 |
| | Function and expression of the Bcl-x gene in the developing and adult nervous system. | Q52205401 |
| | The ATM-mediated DNA-damage response: taking shape. | Q53618038 |
| | Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages | Q71041807 |
| | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation | Q71978735 |
| | RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival | Q74796123 |
| | Improved immunodetection of nuclear antigens after sodium dodecyl sulfate treatment of formaldehyde-fixed cells | Q78055164 |
| | ATM: from gene to function | Q28611464 |
| | ATM and related protein kinases: safeguarding genome integrity | Q29547735 |
| | Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage | Q29614218 |
| | Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM | Q29614843 |
| | Cell cycle checkpoint signaling through the ATM and ATR kinases | Q29617837 |
| | Atm-deficient mice: a paradigm of ataxia telangiectasia | Q29619532 |
| | Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia | Q30516583 |
| | Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. | Q30868748 |
| | Small-molecule activation of neuronal cell fate | Q33343568 |
| | MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation | Q33796329 |
| | Expression and assay of recombinant ATM. | Q33979151 |
| | Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. | Q34087738 |
| | ATM Activation by Oxidative Stress | Q34145092 |
| | ATM and ataxia telangiectasia | Q34166198 |
| | The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain | Q34352305 |
| | Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation | Q34419537 |
| | ATM, a central controller of cellular responses to DNA damage. | Q34425440 |
| | Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients | Q34627156 |
| | Cocaine regulates MEF2 to control synaptic and behavioral plasticity | Q34818266 |
| | Involvement of novel autophosphorylation sites in ATM activation | Q34972885 |
| | ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage | Q35037470 |
| | DNA damage and ageing: new-age ideas for an age-old problem | Q35153827 |
| | Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation | Q35163278 |
| | SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins | Q36072177 |
| | The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice | Q36249548 |
| | Requirement of the MRN complex for ATM activation by DNA damage | Q36267304 |
| | Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. | Q36857310 |
| | Decision tree-driven tandem mass spectrometry for shotgun proteomics | Q37002998 |
| | The role of the DNA damage response in neuronal development, organization and maintenance | Q37155140 |
| | Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria | Q37239235 |
| | Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis | Q37659446 |
| | Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli | Q40312088 |
| | A role for proapoptotic BID in the DNA-damage response | Q40381562 |
| | Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? | Q41639296 |
| | Comprehensive proteomic analysis of Schizosaccharomyces pombe by two-dimensional HPLC-tandem mass spectrometry | Q42074039 |
| | Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures | Q42447104 |
| | Elevated oxidative stress in patients with ataxia telangiectasia | Q44127772 |
| | The selective detection of mitochondrial superoxide by live cell imaging | Q46554007 |
| | Proapoptotic BID is an ATM effector in the DNA-damage response | Q46669145 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| | DNA damage | Q5205747 |
| P304 | page(s) | 4640-4653 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage | |
| P478 | volume | 34 | |